Ionis Pharmaceuticals Inc...

NASDAQ: IONS · Real-Time Price · USD
43.76
0.91 (2.12%)
At close: Aug 15, 2025, 3:59 PM
43.97
0.49%
After-hours: Aug 15, 2025, 07:55 PM EDT

Ionis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-146.94M -104.35M -140.48M -66.27M -142.8M -9.26M -147.41M -85.29M -124.32M -52.43M -46.99M -105.14M -65.17M 224.61M -82.47M -80.88M -89.87M
Depreciation & Amortization
4.82B 5.27M 3.62M 5.58M 5.65M 5.61M 5.59M 5.69M 5.61M 7.03M 5.09M 5.09M 4.89M 4.98M 4.71M 5.01M 4.86M
Stock-Based Compensation
29.72M 36.15M 31.98M 30.73M 31.34M 26.34M 25.96M 26.56M 26.95M 25.69M 23.84M 24.5M 26.24M 22.26M 30.54M 30.02M 37.86M
Other Working Capital
-68.7M -17.29M 132.09M -70.25M -122.45M -49.56M 107.91M -3.5M -56.17M -6.08M -16.85M 33.47M -43.19M -5.14M -18.9M -25.8M -60.18M
Other Non-Cash Items
-4.81B 8.18M -149.66M 4.1M 1.39M 2.55M 4.07M 6.47M 12.78M -149.61M 2.93M 5.94M 6.14M 2.93M 1.72M 1.94M 1.08M
Deferred Income Tax
n/a n/a n/a n/a n/a -5.35M 6.44M -19.23M n/a n/a n/a n/a n/a 4.1M 4.63M 12.57M 4.01M
Change in Working Capital
-41.17M -61.38M 139.55M -94.03M -45.52M 12.99M -3.68M -31.56M -55M -30.88M -9.3M 51.51M -3.76M -55.2M -14.7M -31.32M -12.6M
Operating Cash Flow
-150.78M -116.14M -114.99M -119.88M -149.94M 32.87M -109.02M -97.36M -133.99M -200.19M -24.43M -18.1M -31.65M 203.69M -55.57M -62.65M -54.66M
Capital Expenditures
-12.58M -25.5M -9.06M -20.26M -5.73M 819K -3.24M -13.07M -11.72M -5.01M -7.06M -4.5M -3.53M -3.99M -4.6M -6.31M -3M
Cash Acquisitions
n/a n/a n/a n/a n/a 26.76M 1.1M 1.06M 1.25M 254.08M 178.39M -31K 826M 1.49M 1.28M 1.95M 1.23M
Purchase of Investments
-311.07M -333.63M -715.36M -284.87M -519M -417.71M -420.74M -244.08M -688.28M -261.98M -560.6M -200.34M -462.86M -193.23M -197.43M -410.67M -330.05M
Sales Maturities Of Investments
494.75M 429.89M 370.87M 367.58M 600.84M 390.95M 492.69M 326.67M 374.36M 225.05M 383.73M 201.54M 178.84M 292.33M 324M 315.95M 411.91M
Other Investing Acitivies
-651K -2.55M 12.75M n/a n/a -27.53M -1.1M -1.06M -1.25M n/a -178.39M 31K -826M -1.49M -1.28M -1.95M -1.23M
Investing Cash Flow
170.46M 68.21M -340.8M 62.45M 76.11M -26.71M 68.71M 69.52M -325.64M 212.15M -183.93M -3.3M -287.55M 95.11M 121.97M -101.03M 78.86M
Debt Repayment
-42K -44.55M -48K -39K -39K -38K -67.83M 154.81M -39K -50.6M -89K n/a n/a 90.18M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a 31.84M -13.66M 489.57M -765K -645K -399K -9.17M -137.06M -464K 312.66M -15.34M
Financial Cash Flow
2.2M -44.12M 496.05M 2.56M 23.57M 40.72M -32.27M 143.54M 492.09M -51.02M 1.83M 1.22M -7.33M -62.49M 1.46M 314.54M -7.58M
Net Cash Flow
22.11M -92.53M 40.61M -54.9M -50.38M 47.21M -72.73M 115.76M 32.56M -38.52M -206.92M -20.6M -326.68M 236.24M 67.83M 150.96M 16.49M
Free Cash Flow
-163.35M -141.64M -124.05M -140.14M -155.67M 33.68M -112.26M -110.44M -145.72M -205.2M -31.49M -22.6M -35.18M 199.7M -60.17M -68.96M -57.66M